title: Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection.
abstract: In order to define the optimal extent of resection for cancer of the cardia, we considered 116 patients operated upon with five different surgical techniques. The procedures were: transabdominal total gastrectomy associated with distal esophagectomy in 38 patients; transabdominal total gastrectomy and left thoracotomic esophageal resection at the inferior pulmonary vein level in 26 patients; transabdominal total gastrectomy and right thoracotomic esophageal resection at the azygos vein level in 27 patients; transabdominal total gastrectomy and transhiatal lower third esophagectomy in 18 patients; transhiatal total esophagectomy and upper third gastrectomy with cervical esophago-gastroplasty in seven patients. Grading, staging, neoplastic lymphangitis, satellite intramural metastases, infiltration of the resection margin, site of recurrence, and survival were analyzed. N+ was the single independent prognostic factor for survival. A poorly differentiated grading was related to T (P = 0.0009), N (P = 0.001), satellite growth (P = 0.05), and infiltration of the resection margin (P = 0.0001). Recurrence was local in 26% and distant in 74% of patients. The modalities of recurrence were not related to the aggressiveness parameters and the surgical technique. Infiltration of the esophageal resection margin was related to the type of operation (P = 0.005) and survival (P = 0.02), but it was not related to the site of recurrence. Transabdominal total gastrectomy and the right thoracotomic esophageal resection procedure achieved free margins and control of the lymph nodal metastatic spread. Transabdominal total gastrectomy and right thoracotomic esophageal resection at the azygos vein level provides a radical oncologic resection, particularly in poorly differentiated tumors. However, surgery alone cannot cure the majority of adenocarcinomas of the cardia.
authors.affiliation: Department of Surgery, Intensive Care and Transplants, Center for the Study and Therapy of Diseases of the Esophagus of the University of Bologna, Bologna, Italy. mattioli@med.unibo.it
authors.forename: S
authors.initials: S
authors.lastname: Mattioli
authors.forename: M P
authors.initials: MP
authors.lastname: Di Simone
authors.forename: L
authors.initials: L
authors.lastname: Ferruzzi
authors.forename: F
authors.initials: F
authors.lastname: D'Ovidio
authors.forename: V
authors.initials: V
authors.lastname: Pilotti
authors.forename: R
authors.initials: R
authors.lastname: Carella
authors.forename: A
authors.initials: A
authors.lastname: D'Errico
authors.forename: W F
authors.initials: WF
authors.lastname: Grigioni
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000601:surgery*; D002299:Cardia / Q000473:pathology / Q000601:surgery*; D016629:Esophagectomy; D005500:Follow-Up Studies; D005743:Gastrectomy / Q000379:methods*; D006801:Humans; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D013274:Stomach Neoplasms / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate; D016896:Treatment Outcome